Related Experiment Video
Updated: Jan 28, 2026

Automated Robotic Dispensing Technique for Surface Guidance and Bioprinting of Cells
Published on: November 18, 2016
Valproate MHRA Guidance: Limitations and Opportunities
Lance Watkins1, Hannah Cock2,3, Heather Angus-Leppan4,5,6
1Mental Health and Learning Disability Delivery Unit, Llwyneryr Unit, Neath Port Talbot CLDT, Abertawe Bro Morgannwyg University Health Board, Swansea, United Kingdom.
New UK regulations for valproate medicines require careful consideration for women with intellectual disability (ID). Individualized care is crucial to balance safety with the epilepsy treatment needs of this vulnerable population.
Area of Science:
- Neurology
- Public Health
- Pharmacovigilance
Background:
- The UK Medicines and Healthcare products Regulatory Agency (MHRA) has updated regulations for valproate medicines, emphasizing teratogenic risks for women of childbearing age.
- The directive encourages withdrawal of valproate from women of childbearing age with epilepsy.
- These updated regulations may not adequately consider the unique needs of women with intellectual disability (ID).
Purpose of the Study:
- To examine the challenges in applying the new MHRA valproate directive to women with moderate to profound ID.
- To propose a pathway for informed consent regarding valproate use in women with ID, considering their cognitive abilities.
- To advocate for individualized, person-centered care in managing epilepsy in this vulnerable population.
Main Methods:
- Review of MHRA directives on valproate.
- Analysis of the challenges in obtaining informed consent for women with moderate to profound ID.
- Proposal of a case-by-case approach based on individual cognitive capacity.
Main Results:
- Women with moderate to profound ID may face risks to epilepsy control due to the directive.
- Many individuals with ID have seizures, with a significant portion being treatment-resistant.
- Current directives may not account for the inability of some individuals with ID to provide informed consent.
Conclusions:
- A nuanced, individualized approach is essential when implementing valproate safety directives for women with ID.
- Cognitive ability assessments are crucial for facilitating informed consent and decision-making.
- Collaborative, person-centered care is paramount to ensure the well-being and appropriate treatment of women with ID.
Related Concept Videos
Limiting Reactant
The Number e as a Limit
Central Limit Theorem
The sample size, n, that...
Limits to Natural Selection
Limits on Trigonometric Functions
Accuracy, limits, and approximation
Accuracy is defined as the closeness of the measured value to the true or actual value. In engineering mechanics, repeated measurements are taken during theoretical or experimental analyses to ensure that the result is precise and accurate.
The accuracy of any solution is based on the...

